What non‑loop diuretics are used for hypertension or peripheral edema and what are their typical dosing regimens?

Non-Loop Diuretics for Hypertension and Peripheral Edema

For hypertension, thiazide-type diuretics—particularly chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 25-50 mg daily—are preferred first-line agents, while for peripheral edema with heart failure, thiazide diuretics combined with potassium-sparing agents (spironolactone 12.5-25 mg daily or eplerenone 25-50 mg twice daily) are recommended alongside ACE inhibitors and beta blockers. 1, 2, 1

Thiazide and Thiazide-Like Diuretics

For Hypertension

Chlorthalidone is the preferred thiazide-type diuretic based on its prolonged half-life (24-72 hours) and proven cardiovascular outcome reduction in major trials 2, 3, 4:

• Initial dose: 12.5-25 mg once daily 1, 2
• Maximum dose: 100 mg daily 1
• Chlorthalidone is more potent than hydrochlorothiazide at equivalent doses—25 mg chlorthalidone provides greater 24-hour blood pressure reduction than 50 mg hydrochlorothiazide 5, 6

Hydrochlorothiazide (HCTZ) remains widely used despite shorter duration of action (6-12 hours) 1:

• Initial dose: 25 mg once or twice daily 1, 2
• Maximum dose: 200 mg daily 1
• For proven cardiovascular outcomes, use 25-50 mg daily based on trial evidence 3, 4

Indapamide offers intermediate-acting properties (36 hours) with favorable metabolic profile 1:

• Initial dose: 2.5 mg once daily 1
• Maximum dose: 5 mg daily 1
• Particularly effective in elderly patients and those with prior stroke when combined with ACE inhibitors 7, 4

Other thiazide options 1:

• Chlorothiazide: 250-500 mg once or twice daily (maximum 1000 mg/day)
• Metolazone: 2.5 mg once daily (maximum 20 mg/day)—reserve for resistant hypertension or refractory edema 1, 8

For Peripheral Edema

Thiazides are less effective than loop diuretics for significant volume overload but have important roles 1, 9, 1:

• Use thiazides in mild fluid retention with hypertension for dual blood pressure and volume control 1
• In heart failure with preserved ejection fraction, thiazides provide antihypertensive benefit while managing mild congestion 9
• Avoid thiazides as monotherapy in moderate-to-severe heart failure or when GFR <30 mL/min—loop diuretics are required 2, 10

Potassium-Sparing Diuretics

Mineralocorticoid Receptor Antagonists (MRAs)

Spironolactone is the most evidence-based potassium-sparing agent for both hypertension and heart failure 1, 9, 1:

• For heart failure: 12.5-25 mg once daily initially (maximum 50 mg daily) 1, 11
• For resistant hypertension: 25-50 mg once daily 8, 12, 13
• Proven mortality benefit in heart failure with reduced ejection fraction when combined with ACE inhibitors, beta blockers, and diuretics 1, 9
• Major limitation: gynecomastia and sexual dysfunction in 10-40% of patients 12, 13

Eplerenone provides more selective MR blockade with fewer sexual side effects 9, 10, 13:

• Initial dose: 25-50 mg twice daily 10
• Maximum dose: 100 mg daily (often requires twice-daily dosing for adequate blood pressure control) 2, 10
• Alternative when spironolactone causes intolerable side effects 12, 13

Critical safety considerations for MRAs 1, 9, 8:

• Contraindicated if serum creatinine ≥2.5 mg/dL (men) or ≥2.0 mg/dL (women), or potassium ≥5.0 mEq/L 9
• Avoid if eGFR <45 mL/min 2, 8
• Monitor potassium frequently, especially when combined with ACE inhibitors or ARBs 1, 9
• Risk of severe hyperkalemia increases substantially with combination therapy 14, 1

Other Potassium-Sparing Agents

Amiloride 1, 10:

• Initial dose: 5 mg once daily
• Maximum dose: 20 mg daily
• Duration: 24 hours
• Alternative to spironolactone in resistant hypertension when MRAs contraindicated 8, 12

Triamterene 1, 10:

• Initial dose: 50-75 mg twice daily
• Maximum dose: 200 mg daily
• Duration: 7-9 hours
• Typically prescribed as fixed-dose combination with hydrochlorothiazide 13

Clinical Application Algorithms

For Hypertension Without Compelling Indications

1. First-line monotherapy: Chlorthalidone 12.5-25 mg daily OR hydrochlorothiazide 25-50 mg daily 2, 3, 15
2. Black patients: Thiazides or calcium channel blockers preferred over ACE inhibitors/ARBs 3
3. Elderly/isolated systolic hypertension: Thiazides particularly effective 2, 16
4. If inadequate response: Add second agent from different class (ACE inhibitor, ARB, or calcium channel blocker) 2, 3

For Resistant Hypertension

1. Optimize thiazide therapy: Switch to chlorthalidone 12.5-25 mg daily if using hydrochlorothiazide 12
2. Add spironolactone 25-50 mg daily as fourth agent if potassium <4.5 mEq/L and eGFR >45 mL/min 8, 12
3. If spironolactone not tolerated: Use eplerenone, amiloride, or doxazosin 8, 12
4. Sequential nephron blockade: Add metolazone 2.5-10 mg daily to existing thiazide for synergistic effect in refractory cases 1

For Heart Failure With Reduced Ejection Fraction

1. Diuretics for congestion: Thiazides for mild fluid retention; loop diuretics for moderate-severe 1, 11
2. Add MRA for mortality benefit: Spironolactone 12.5-25 mg daily (or eplerenone 25-50 mg twice daily) 1, 9, 1
3. Combine with GDMT: ACE inhibitor/ARB + beta blocker + diuretic regimen 1, 9, 11
4. For refractory edema: Add metolazone 2.5 mg to loop diuretic (reserve for non-responders to moderate-high dose loop diuretics) 1, 11

For Chronic Kidney Disease

1. GFR 30-60 mL/min: Thiazides remain effective for hypertension 2, 7
2. GFR <30 mL/min: Switch to loop diuretics; thiazides ineffective for volume control 2, 10
3. Proteinuric CKD: Thiazides as add-on to ACE inhibitor/ARB for blood pressure control 7

Important Caveats and Monitoring

Electrolyte monitoring is mandatory 14, 1:

• Check sodium, potassium, and creatinine shortly after initiation and periodically thereafter
• Thiazides cause hypokalemia and hyponatremia—chlorthalidone has higher risk than hydrochlorothiazide due to longer half-life 17
• MRAs cause hyperkalemia—risk amplified with ACE inhibitors/ARBs or renal dysfunction 1, 9

Metabolic effects 5, 18:

• Thiazides may worsen glucose tolerance and increase uric acid
• Thiazide-induced hypokalemia correlates with glucose intolerance—correcting potassium may prevent diabetes 5
• Use cautiously in gout unless patient receives allopurinol 2, 16

Drug interactions 5:

• NSAIDs blunt thiazide effectiveness
• Beta blockers combined with thiazides may increase fatigue and glucose

Contraindications 2, 9, 10:

• Pregnancy (all classes)
• Severe renal impairment for thiazides (GFR <30) and potassium-sparing agents (GFR <45)
• History of angioedema does not apply to diuretics (relevant for ACE inhibitors/ARBs often combined with diuretics)